B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KYAT1

MOLECULAR TARGET

kynurenine aminotransferase 1

UniProt: Q16773NCBI Gene: 8831 compounds

KYAT1 (kynurenine aminotransferase 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KYAT1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Tryptophan0.691

About KYAT1 as a Drug Target

KYAT1 (kynurenine aminotransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented KYAT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KYAT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.